Ecolab produces and markets cleaning and sanitation products for the industrial manufacturing, data center, hospitality, healthcare, and life sciences markets... Show more
Ecolab shares have traded within a relatively contained range in recent weeks, pulling back from mid-June levels near $276 to the $268–$273 band by late July. The stock's 50-day moving average sits near $263, while the 200-day moving average was approximately $272, indicating a period of consolidation after earlier 2026 gains. Broader sentiment around the specialty chemicals and water solutions sector remains constructive, though near-term pressure from elevated commodity and energy costs has tempered enthusiasm. Ecolab's market capitalization stands at roughly $78 billion, with the stock changing hands at approximately 33 times trailing earnings.
Ecolab Inc. is a global leader in water, hygiene, and infection prevention solutions, serving customers across more than 170 countries and 40 industries. The company delivers approximately $16 billion in annual sales and employs roughly 48,000 associates. Its operations are organized across four primary segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. Ecolab's products and services span cleaning and sanitizing chemicals, water treatment systems, pest elimination, and digital monitoring technologies for industries including food and beverage, healthcare, hospitality, semiconductor manufacturing, and data centers. The company's competitive advantages include deep customer relationships, proprietary digital platforms, and a growing footprint in high-growth verticals such as AI infrastructure and bioprocessing. Its 40-year track record of consecutive annual dividend increases underscores financial durability.
The most significant catalyst in recent weeks was the early completion of Ecolab's $4.75 billion acquisition of CoolIT Systems, a provider of direct liquid cooling solutions for high-density data centers. CoolIT's year-to-date sales have grown more than 100%, driven by surging demand for liquid cooling in AI data centers. The deal, which closed ahead of schedule in early July, brings Ecolab's Global High-Tech business to approximately $1.5 billion in annualized sales — a dramatic leap from roughly $150 million in 2021.
Management updated its full-year 2026 adjusted EPS guidance to a range of $8.03 to $8.23, reflecting a short-term drag of approximately $0.20 per share per quarter in the second half of 2026 from non-cash amortization and financing costs tied to the acquisition. Beyond 2026, the company expects adjusted EPS growth to return to its long-term 12%–15% target range.
On the analyst front, Oppenheimer upgraded Ecolab to Outperform with a $320 price target on July 17, citing improving momentum across core businesses and accelerating contributions from high-growth segments. UBS upgraded the stock to Buy in late May, while Deutsche Bank, Citi, BMO Capital, and Bank of America have all reiterated Buy ratings with price targets ranging from $325 to $345. Wells Fargo maintains an Equal Weight rating with a $275 target.
The company's first-quarter 2026 results, reported in late April, showed adjusted EPS of $1.70 — up 13% year over year — on revenue of $4.07 billion, which exceeded consensus estimates. Organic sales growth accelerated to 4%, led by Life Sciences, Global High-Tech, Institutional, and Specialty.
Tickeron's Trending AI Robots page provides traders and investors with a curated view of the platform's top-performing AI-powered trading bots. While Tickeron hosts hundreds of bots that actively trade thousands of tickers across diverse strategies and timeframes, only those demonstrating consistently strong performance and relevance earn a spot in this featured section. Bots vary by trading style — ranging from swing trading to longer-term trend following — and are evaluated on metrics including win rate, drawdown, and risk-adjusted returns. For traders seeking data-driven insights and automated execution, the Trending AI Robots page offers a streamlined way to identify bots aligned with current market conditions and individual investment objectives.
Ecolab's immediate catalyst is its Q2 2026 earnings report on July 28. Consensus expectations call for revenue of $4.4 billion and adjusted EPS of $2.08, representing year-over-year growth of 9.3% and 10.1%, respectively. Investors will scrutinize management's commentary on pricing realization, margin recovery, and the pace at which energy surcharges offset elevated commodity costs. The Q2 period was characterized by management as a transitional quarter, with input cost pressures expected to progressively recede through the second half.
Longer term, the integration of CoolIT and the planned launch of the 3D TRASAR cooling platform at the Supercomputing conference in November 2026 represent pivotal milestones. The global data center liquid cooling market, estimated at $6.65 billion in 2025, is projected by Grand View Research to reach $29.46 billion by 2033, growing at a 20.1% compound annual rate — a trajectory that directly supports Ecolab's $4 billion sales target for its Global High-Tech segment by 2030.
Key risk factors include the pace of CoolIT integration, potential macroeconomic headwinds affecting institutional end markets, commodity and energy cost volatility, and foreign exchange exposure. On the positive side, accelerating AI infrastructure spending, continued biopharmaceutical demand strength, and Ecolab's pricing power across its diversified portfolio provide a robust foundation for the company's growth ambitions. With the Nalco amortization roll-off expected to begin in 2027, earnings comparisons could also benefit from reduced non-cash charges in the years ahead.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ECL declined for three days, in of 287 cases, the price declined further within the following month. The odds of a continued downward trend are .
The 10-day RSI Indicator for ECL moved out of overbought territory on July 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 52 similar instances where the indicator moved out of overbought territory. In of the 52 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
ECL broke above its upper Bollinger Band on July 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on July 28, 2026. You may want to consider a long position or call options on ECL as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for ECL just turned positive on July 29, 2026. Looking at past instances where ECL's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .
ECL moved above its 50-day moving average on July 24, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ECL advanced for three days, in of 330 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 269 cases where ECL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ECL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.770) is normal, around the industry mean (6.961). P/E Ratio (37.266) is within average values for comparable stocks, (33.620). Projected Growth (PEG Ratio) (2.863) is also within normal values, averaging (72.205). Dividend Yield (0.010) settles around the average of (0.021) among similar stocks. P/S Ratio (4.682) is also within normal values, averaging (68.060).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of cleaning, sanitizing, pest control, maintenance and repair products and services
Industry ChemicalsSpecialty